Xolair 150 MG/ML syringeml

Ended Awarded

Contract number
SPE2DX24FDEBG
Awardee
Awarding agency
Obligated
$7,737

Award facts

Contract value 100% obligated
$7,737.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $7,737 against its indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. The delivery order was awarded on November 2, 2023 and has a completion date of November 27, 2023. The contract vehicle, held with the Defense Logistics Agency Troop Support Medical since December 2025, provides pharmaceutical items and medical supplies with a potential value of up to $5 million to support military treatment facilities worldwide. No set-aside designation was applied to this delivery order award.

Quick answers

Who was awarded contract SPE2DX24FDEBG?

SPE2DX24FDEBG was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on November 2, 2023.

How much is contract SPE2DX24FDEBG worth?

The government has obligated $7,737 on SPE2DX24FDEBG.

Is contract SPE2DX24FDEBG an order under another contract?

Yes. SPE2DX24FDEBG is a delivery order under SPE2DX15D9312, an indefinite delivery contract.

Was contract SPE2DX24FDEBG competed?

The extent of competition for SPE2DX24FDEBG was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login